PFIZER INC

04 December, 2024

Pfizer Faces Stock Volatility Amid Potential for Long-Term Growth and Attractive Dividend Yield

Pfizer Inc. has faced significant stock challenges, with shares declining approximately 16% over the past year and 10.4% recently due to post-election market volatility. However, analysts are optimist...
Read More

03 December, 2024

Pfizer Maintains Strong Dividend and Growth Potential Amid Stock Challenges and Declining COVID Sales

Pfizer Inc. is in a transformative phase as it navigates significant market dynamics, but it remains an appealing option for income-focused investors. Despite its shares halving since the end of 2022 ...
Read More

02 December, 2024

Pfizer Shows Strong Dividend Performance and Growth Potential Amid Stock Challenges and Market Uncertainty

Pfizer has positioned itself as a significant player in the pharmaceutical market, despite facing a tumultuous year marked by a 10.4% decline in share price year-to-date and a 29% drop over the past f...
Read More

01 December, 2024

Pfizer Sees Boost in Earnings Estimates for 2024 and 2025 Despite Year-to-Date Share Decline

Pfizer (PFE) is showing encouraging trends in earnings estimates, which have recently increased significantly. Projections for the company's earnings per share (EPS) for 2024 have risen from $2.62 to ...
Read More